![]() Hirsutism and male pattern balding consistent with hyperandrogenism.In addition, symptoms may vary with population group, for example, southeast Asian women are less likely to have hirsutism. This is true of Australian Indigenous women, possibly due to higher levels of insulin resistance and higher rates of obesity. It is important to be aware that some population groups have a higher risk of PCOS. Women are at risk if they have a genetic predisposition, and the onset of symptoms can be triggered by environmental factors, particularly obesity. Hyperandrogenaemia and insulin resistance are pathophysiological features of PCOS. The prevalence of metabolic features increases with age but can also occur in younger women who are overweight. In younger women, reproductive symptoms predominate. There are a range of symptoms that women may experience and present with if they have PCOS and these can vary with age (Table 2). Other aetiologies must be excluded such as congenital adrenal hyperplasia, androgen secreting tumours, Cushing syndrome, thyroid dysfunction and hyperprolactinaemia biochemical (raised FAI or free testosterone).clinical (hirsutism or less commonly male pattern alopecia) or.Two of the following three criteria are required: Diagnostic criteria for Rotterdam diagnosis of polycystic ovary syndrome The Rotterdam Criteria require the presence of two of the following: oligo/anovulation, hyperandrogenism or polycystic ovaries on ultrasound 5 (Table 1). It encompasses the National Institutes of Health definition, which generally describes women with a more severe form of PCOS and requires the presence of both hyperandrogenism and oligo/anovulation. While there are a number of definitions of PCOS, the Rotterdam consensus is the most widely accepted across Europe, Asia and Australia and was the definition used for the guideline. (Indigenous in this article refers to the two Indigenous populations of Australia: Aboriginal and Torres Strait Islander people.) Definitions This article attempts to summarise recommendations from the guideline 4 with consideration also given to the needs of Indigenous Australian women. Recently developed GP and consumer targeted assessment and management resources have been informed by the guideline and are available online (see Resources). The 2011 Evidence-based guideline for the assessment and management of polycystic ovary syndrome provides valuable advice to general practitioners on evidence based diagnosis and management.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |